Prediction of anticoagulation during hemodialysis by population kinetics and an artificial neural network

Artificial Organs

Volumn 22, Issue 9, 1998, Pages 731-739

  Smith, Brian P ^a   Ward, Richard A ^a   Brier, Michael E ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Hemodialysis; Heparin; Neural network; Population Pharmacodynamics

Indexed keywords

FORECASTING; HEMODIALYZERS; NEURAL NETWORKS; POLYSACCHARIDES; POPULATION STATISTICS;

ANTI-COAGULATION; BLOOD CLOTTING; CLOTTING TIME; HAEMODIALYSIS; MIXED EFFECTS MODELS; NEURAL-NETWORKS; NONLINEAR MIXED EFFECTS; POPULATION KINETICS; POPULATION PHARMACODYNAMIC; STATISTICAL TECHNIQUES;

DIALYSIS;

HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL NEURAL NETWORK; BLOOD CLOTTING TIME; DOSE CALCULATION; DOSE RESPONSE; ENDOTHELIUM CELL; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHARMACODYNAMICS; POPULATION DYNAMICS; PREDICTION; PRIORITY JOURNAL;

EID: 0031781431     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06101.x     Document Type: Article

References (19)

1. Wei SS, Ellis PW, Magnusson MO, Paganini EP. Effect of heparin modeling on delivered hemodialysis therapy. Am J Kidney Dis 1994;23:389-93.
2. Farrell PC, Ward RA, Schindhelm K, Gotch FA. Precise anticoagulation for routine hemodialysis. J Lab Clin Med 1978; 92:164-76.
3. Kandrotas RJ, Gal P, Douglas JB, Deterding J. Pharmacokinetics and pharmacodynmics of heparin during hemodialysis: Interpatient and intrapatient variability. Pharmacotherapy 1990;10:349-56.
4. Jannett TC, Wise MG, Shanklin NH, Sanders PW. Adaptive control of anticoagulation during hemodialysis. Kidney Int 1994;45:912-5.
5. Wilhelmsson S, Lins L-E. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: A comparison of administration by single-dose and by infusion. Clin Nephrol 1983;19:82-6.
6. Beal SL, Sheiner LB, eds. NONMEM users guides. NONMEM Project Group. San Francisco: University of California at San Francisco, 1992.
7. Smith BP, Brier ME. Statistical approach to neural network model building for gentamicin peak predictions. J Pharm Sci 1996;85:65-9.
8. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokin Biopharm 1981;9:503-12.
9. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters III. Monoexponential model: Routine clinical pharmacokinetic data. J Pharmacokin Biopharm 1983;11:303-19.
10. Ludden TM, Mungall DR, Raskob GE, Hull RD. A mixed effects model for heparin phramacokinetics and pharmacodynamics. Clin Pharmacol Ther 1987;41:176.
11. Veng-Pedersen P, Modi NB. Application of neural networks to pharmacodynamics. J Pharm Sci 1993;82:918-26.
12. Brier ME, Zurada JM, Aronoff GR. Neural network predicted peak and trough gentamicin concentrations. Pharm Res 1995;12:406-12.
13. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Int Med 1993;119:874-81.
14. Gunnarsson PS, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin. Empiric vs nomogram-based dosing. Arch Intern Med 1995;155:526-32.
15. Rosenberg RD. The heparin-antithrombin system: A natural anticoagulant mechanism. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis. Basic principles and clinical practice 2nd edition. Philadelphia: JB Lippincott, 1987:1373-92.
16. Barzu T, van Rijn JLML, Petitou M, Tobelem G, Caen JP. Heparin degradation in the endothelial cells. Thromb Res 1987;47:601-9.
17. Dawes J, Pepper DS. Catabolism of low-dose heparin in man. Thromb Res 1979;14:845-60.
18. de Swart CAM, Nijmeyer B, Roelofs JMM, Sixma JJ. Kinetics of intravenously administered heparin in normal humans. Blood 1982;60:1251-8.
19. Holland FF, Gidden HE, Mason RG, Klein E. Thrombogenicity of heparin-bound DEAE cellulose hemodialysis membranes. ASAIO J 1978;1:24-36.